Oric Pharmaceuticals Stock Price on December 18, 2024

ORIC Stock  USD 8.25  0.01  0.12%   
Below is the normalized historical share price chart for Oric Pharmaceuticals extending back to April 24, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Oric Pharmaceuticals stands at 8.25, as last reported on the 18th of December 2024, with the highest price reaching 8.35 and the lowest price hitting 7.90 during the day.
IPO Date
24th of April 2020
200 Day MA
9.904
50 Day MA
9.3408
Beta
1.122
 
Covid
If you're considering investing in Oric Stock, it is important to understand the factors that can impact its price. Oric Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11% return per unit of risk over the last 3 months. Oric Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oric Pharmaceuticals' Variance of 13.43, coefficient of variation of (1,652), and Risk Adjusted Performance of (0.04) to confirm the risk estimate we provide.
  
As of December 18, 2024, Common Stock is expected to decline to 3,614. In addition to that, Total Stockholder Equity is expected to decline to about 189.3 M. As of December 18, 2024, Price Earnings Ratio is expected to decline to -4.94. In addition to that, Price Book Value Ratio is expected to decline to 2.01. Oric Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.114

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsORIC

Estimated Market Risk

 3.62
  actual daily
32
68% of assets are more volatile

Expected Return

 -0.41
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Oric Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oric Pharmaceuticals by adding Oric Pharmaceuticals to a well-diversified portfolio.
Price Book
2.1222
Book Value
3.883
Enterprise Value
312.2 M
Enterprise Value Ebitda
0.1311
Shares Float
42.7 M

Related Headline

Molecular Partners Headline on 17th of December 2024

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Dec. 17, 2024 -- Molecular Partners AG , a clinical-stage biotech company

Oric Pharmaceuticals Valuation on December 18, 2024

It is possible to determine the worth of Oric Pharmaceuticals on a given historical date. On December 18, 2024 Oric was worth 8.18 at the beginning of the trading date compared to the closed value of 8.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oric Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Oric Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oric Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oric Pharmaceuticals' related companies.
 Open High Low Close Volume
  8.28    8.62    8.13    8.24    598,498  
12/17/2024
  8.18    8.35    7.90    8.25    321,134  
Backtest Oric Pharmaceuticals  |  Oric Pharmaceuticals History  |  Oric Pharmaceuticals Valuation   Previous
Open Value
8.18
8.25
Closing Value
19.03
Upside

Oric Pharmaceuticals Trading Date Momentum on December 18, 2024

On December 17 2024 Oric Pharmaceuticals was traded for  8.25  at the closing time. The top price for the day was 8.35  and the lowest listed price was  7.90 . The trading volume for the day was 321.1 K. The trading history from December 17, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.85% .

Oric Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Oric Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oric Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oric financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Oric Pharmaceuticals Stock history

Oric Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oric is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oric Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oric Pharmaceuticals stock prices may prove useful in developing a viable investing in Oric Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding51.5 M36.7 M
Net Loss-80.2 M-84.2 M

Oric Pharmaceuticals Quarterly Net Working Capital

258.18 Million

Oric Pharmaceuticals Stock Technical Analysis

Oric Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Oric Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Oric Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Oric Pharmaceuticals Period Price Range

Low
December 18, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Oric Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Oric Pharmaceuticals December 18, 2024 Market Strength

Market strength indicators help investors to evaluate how Oric Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oric Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Oric Pharmaceuticals stock market strength indicators, traders can identify Oric Pharmaceuticals entry and exit signals to maximize returns

Oric Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Oric Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Oric Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oric to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Oric Stock analysis

When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges